MR Susceptibility Imaging with a Short TE (MR-SISET): A Clinically Feasible Technique to Resolve Thalamic Nuclei

References

1. 1.↵
   2. Benabid AL,
   3. Pollak P,
   4. Gervason C, et al

   . Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 1991;337:403–06 doi:10.1016/0140-6736(91)91175-t pmid:1671433

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Son BC,
   3. Shon YM,
   4. Choi JG, et al

   . Clinical outcome of patients with deep brain stimulation of the centromedian thalamic nucleus for refractory epilepsy and location of the active contacts. Stereotact Funct Neurosurg 2016;94:187–97 doi:10.1159/000446611 pmid:27434073

   CrossRefPubMed
3. 3.↵
   2. Vandewalle V,
   3. van der Linden C,
   4. Groenewegen HJ, et al

   . Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus. Lancet 1999;353:724 doi:10.1016/s0140-6736(98)05964-9 pmid:10073521

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Morel A,
   3. Magnin M,
   4. Jeanmonod D

   . Multiarchitectonic and stereotactic atlas of the human thalamus. J Comp Neurol 1997;387:588–630 doi:10.1002/(SICI)1096-9861(19971103)387:4<588::AID-CNE8>3.0.CO;2-Z pmid:9373015

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Sammartino F,
   3. Krishna V,
   4. King NK, et al

   . Tractography-based ventral intermediate nucleus targeting: novel methodology and intraoperative validation. Mov Disord 2016;31:1217–25 doi:10.1002/mds.26633

   CrossRefPubMed
6. 6.↵
   2. Morel A

   . Stereotactic Atlas of the Human Thalamus and Basal Ganglia. Informa Healthcare; 2007:13–53
7. 7.↵
   2. Lancione M,
   3. Tosetti M,
   4. Donatelli G, et al

   . The impact of white matter fiber orientation in single-acquisition quantitative susceptibility mapping. NMR Biomed 2017;30:doi:10.1002/nbm.3798 doi:10.1002/nbm.3798 pmid:28902421

   CrossRefPubMed
8. 8.↵
   2. Abosch A,
   3. Yacoub E,
   4. Ugurbil K, et al

   . An assessment of current brain targets for deep brain stimulation surgery with susceptibility-weighted imaging at 7 Tesla. Neurosurgery 2010;67:1745–56; discussion 1756 doi:10.1227/NEU.0b013e3181f74105 pmid:21107206

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Deistung A,
   3. Schafer A,
   4. Schweser F, et al

   . Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength. Neuroimage 2013;65:299–314 doi:10.1016/j.neuroimage.2012.09.055 pmid:23036448

   CrossRefPubMed
10. 10.↵
    2. Liu T,
    3. Xu W,
    4. Spincemaille P, et al

    . Accuracy of the morphology enabled dipole inversion (MEDI) algorithm for quantitative susceptibility mapping in MRI. IEEE Trans Med Imaging 2012;31:816–24 doi:10.1109/TMI.2011.2182523 pmid:22231170

    CrossRefPubMed
11. 11.↵
    2. Sood S,
    3. Urriola J,
    4. Reutens D, et al

    . Echo time-dependent quantitative susceptibility mapping contains information on tissue properties. Magn Reson Med 2017;77:1946–58 doi:10.1002/mrm.26281 pmid:27221590

    CrossRefPubMed